Fenbendazole treatment against Dentostomella translucida in Syrian golden hamsters.
Dentostomella translucida
Fenbendazole
Pinworms
Syrian golden hamster
Journal
Experimental parasitology
ISSN: 1090-2449
Titre abrégé: Exp Parasitol
Pays: United States
ID NLM: 0370713
Informations de publication
Date de publication:
Feb 2023
Feb 2023
Historique:
received:
25
07
2022
revised:
13
12
2022
accepted:
30
12
2022
pubmed:
3
1
2023
medline:
21
1
2023
entrez:
2
1
2023
Statut:
ppublish
Résumé
Dentostomella translucida is an oxyurid nematode that was first discovered in the Mongolian gerbil but has also been detected in other wild and housed rodents. In conventional laboratory animals, oxyurid nematode parasites are widespread infections. A proven treatment strategy for pinworm eradication is the oral application of benzimidazoles, such as fenbendazole. In general, this drug is regarded as safe with minimal side effects. Nevertheless, in Sprague Dawley rats, a significantly reduced litter size could be seen after longer treatment with fenbendazole. Even though Dentostomella translucida was already described in Syrian golden hamsters (Mesocricetus auratus), data on treatment with fenbendazole and its effects on reproduction is lacking. Therefore, the main purposes of the study were (1) the verification of the effectiveness of fenbendazole as medicated feed (150 ppm) against this parasite in naturally infected Syrian golden hamsters in conventional husbandry and (2) monitoring of possible effects on reproduction during the treatment. Results show that fenbendazole treatment was highly effective against Dentostomella translucida, as numbers of pinworm eggs in the faeces were significantly reduced already after the first week of treatment in all animals. After four weeks of treatment, eggs were eradicated entirely. Interestingly, the average weaning weight was significantly reduced during treatment, but the litters were in good health.
Identifiants
pubmed: 36592712
pii: S0014-4894(22)00252-1
doi: 10.1016/j.exppara.2022.108458
pii:
doi:
Substances chimiques
Fenbendazole
621BVT9M36
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
108458Informations de copyright
Copyright © 2023 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.